Showing results (81-90 of 95) with videos related to
Sort By:
Pageof 10
Neuroepidemiology|February 5, 2003
Ambient air quality and occurrence of multiple sclerosis relapseM Oikonen, M Laaksonen, P Laippala, et al.The Journal of Biological Chemistry|February 15, 2000
Human peroxisomal multifunctional enzyme type 2. Site-directed mutagenesis studies show the importance of two protic residues for 2-enoyl-CoA hydratase 2 activityY M Qin, A M Haapalainen, S H Kilpeläinen, et al.Vaccine|July 6, 2010
J-LEAPS vaccines initiate murine Th1 responses by activating dendritic cellsP R Taylor, G K Koski, C C Paustian, et al.Plos One|February 6, 2013
Extracellular ATP and Toll-like receptor 2 agonists trigger in human monocytes an activation program that favors T helper 17Christopher Paustian, Patricia Taylor, Terrence Johnson, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2000
Granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-12 synergize with calcium ionophore to enhance dendritic cell functionI Bedrosian, J G Roros, S Xu, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 2, 2011
A novel dendritic cell-based immunization approach for the induction of durable Th1-polarized anti-HER-2/neu responses in women with early breast cancerGary K Koski, Ursula Koldovsky, Shuwen Xu, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 23, 1997
Calcium ionophore-treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cellsB J Czerniecki, C Carter, L Rivoltini, et al.Diabetologia|December 15, 2010
The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study: recruitment, intervention and follow-up, H K Akerblom, J Krischer, et al.Oncoimmunology|September 22, 2017
Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ER<sup>pos</sup>/HER2<sup>pos</sup> early breast cancerLea Lowenfeld, Salman Zaheer, Crystal Oechsle, et al.Blood|June 26, 2008
STAT3- and STAT5-dependent pathways competitively regulate the pan-differentiation of CD34pos cells into tumor-competent dendritic cellsPeter A Cohen, Gary K Koski, Brian J Czerniecki, et al.Pageof 10